Martine Rothblatt

2011

In 2011, Martine Rothblatt earned a total compensation of $3.2M as Chief Executive Officer at United Therapeutics, a 82% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,409,730
Non-Equity Incentive Plan$804,960
Salary$931,485
Other$15,175
Total$3,161,350

Rothblatt received $1.4M of change in pension value and nonqualified deferred compensation earnings, accounting for 45% of the total pay in 2011.

Rothblatt also received $805K in non-equity incentive plan, $931.5K in salary and $15.2K in other compensation.

Rankings

In 2011, Martine Rothblatt's compensation ranked 2,004th out of 10,747 executives tracked by ExecPay. In other words, Rothblatt earned more than 81.4% of executives.

ClassificationRankingPercentile
All
2,004
out of 10,747
81st
Division
Manufacturing
722
out of 3,958
82nd
Major group
Chemicals And Allied Products
154
out of 1,031
85th
Industry group
Drugs
87
out of 779
89th
Industry
Pharmaceutical Preparations
73
out of 567
87th
Source: SEC filing on April 30, 2014.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2011.

2011

Roger Jeffs

United Therapeutics

Chief Operating Officer

2011

Paul Mahon

United Therapeutics

General Counsel

2011

John Ferrari

United Therapeutics

Chief Financial Officer

News

You may also like